Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Correlation between the inhibitory activities of calcium entry blockers on vascular smooth muscle constriction in vitro after K+-depolarisation and in vivo afterα 2-adrenoceptor stimulation


Calcium entry blockers are known to depress the maximal increase in diastolic pressure induced in pithed rats by selective α2-adrenoceptor stimulation. In order to substantiate the relevance of calcium fluxes in this interaction, a correlation between the potency of calcium entry blockers in pithed rats and their calcium antagonistic potency in vitro was investigated. Accordingly, the inhibition of calcium entry blockers with respect to α2-adrenoceptor-mediated vasoconstriction was quantified in terms of −log ID50 values. As a measure of calcium antagonistic potency, the inhibitory activity of a number of calcium entry blockers on K+-induced contractions of rabbit thoracic aorta strips was determined and the negative logarithms of the 50% inhibitory concentrations, −log IC50, were calculated. A highly significant linear relationship was found between the in vitro, −log IC50, and the in vivo parameter, −log ID50, of the calcium entry blockers. This result suggests a similar type of interaction for the calcium entry blockers in vivo and in vitro, i.e. inhibition of a transmembrane influx of extracellular calcium.

This is a preview of subscription content, log in to check access.


  1. Bolton TB (1979) Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev 59:606–718

  2. Diem K, Lentner C (1970) In: Diem K, Lentner C (eds) Statistical methods. Documenta Geigy. Basel, Geigy, pp 174–183

  3. Draper NR, Smith H (1966) Applied regression analysis. Wiley, New York

  4. Fleckenstein A, Fleckenstein-Grün G, Byon YK, Haastert HP, Spah F (1979) Vergleichende Untersuchungen über die Ca2+-antagonistischen Grundwirkungen von Niludipin (Bay a 7168) und Nifedipin (Bay a 1040) auf Myocard, Myometrium und glatten Gefäßmuskulatur. Arzneimittelforsch 29:230–246

  5. Fleckenstein-Grün G, Fleckenstein A (1980) Calcium-Antagonismus, ein Grundprinzip der Vasodilatation. In: Fleckenstein A, Roskamm H (eds) Calcium antagonismus. Springer, Berlin Heidelberg New York, pp 191–207

  6. Godfraind T, Kaba A (1972) The role of calcium in the action of drugs on vascular smooth muscle. Arch Int Pharmacodyn 196:35–49

  7. Grün G, Fleckenstein A (1972) Die elektromechanische Entkoppelung der glatten Gefäßmuskulatur als Grundprinzip der Coronardilatation durch 4-(2′-Nitrophenyl)2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsäure-dimethylester (BAY a 1040, Nifedipine). Arzneimittelforsch 22:334–344

  8. Haeusler G (1972) Differential effect of verapamil on excitation-contraction coupling in smooth muscle and excitation-secretion coupling in adrenergic nerve terminals. J Pharmacol Exp Ther 180:672–682

  9. Ishii H, Itoh K, Nose T (1980) Different antihypertensive effects of nifedipine in conscious experimental hypertensive and normotensive rats. Eur J Pharmacol 64:21–29

  10. Kazda S, Garthoff B, Meyer H, Schlossman K, Stoepel K, Towart R, Vater W, Wehinger E (1980) Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylate (Nisoldipine, Bay k 5552). Arzneimittelforsch 30:2144–2162

  11. Knorr A, Stoepel K (1981) Effect of a new calcium antagonist, nitrendipine, on blood pressure and heart rate of conscious, unrestraint dogs. Arzneimittelforsch 31:2062–2064

  12. Kobinger W, Pichler L (1980) Investigation into different types of post- and presynaptic α-adrenoceptors at cardiovascular sites in rat. Eur J Pharmacol 65:393–402

  13. Kondo K, Suzuki H, Okuno T, Suda M, Saruto T (1980) Effects of nifedipine, diltiazem and verapamil on the vasoconstrictor responses to epinephrine and potassium ions in the rat mesenteric artery. Arch Int Pharmacodyn 245:211–217

  14. Lederballe Pedersen O, Christensen NJ, Rämsch KD (1980) Comparison of acute effects of nifedipine in normotensive and hypertensive man. J Cardiovasc Pharmacol 2:357–366

  15. Massingham R (1973) A study of compounds which inhibit vascular smooth muscle contraction. Eur J Pharmacol 22:75–82

  16. Olivari MT, Bartorelli C, Polese A, Fiorentini C, Moruzzi P, Guazzi MD (1979) Treatment of hypertension with nifedipine, a calcium antagonistic agent. Circulation 59:1056–1062

  17. Schümann HJ, Görlitz BD, Wagner J (1975) Influence of papaverine D 600 and nifedipine on the effects of noradrenaline and calcium on the isolated aorta and mesenteric artery of the rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 289:409–418

  18. Thorens S, Haeusler G (1979) Effects of some vasodilators on calcium translocation in intact and fractionated vascular smooth muscle. Eur J Pharmacol 54:79–91

  19. Thuillez C, Giudicelli JF (1981) Pharmacologie cardio-vasculaire des antagonistes du calcium. Thérapie 36:107–121

  20. Timmermans PBMWM (1981) Calcium antagonism and α2-adrenoceptor activation. Naunyn-Schmiedeberg's Arch Pharmacol 316 (Suppl): R57

  21. Towart R (1981) The selective inhibition of serotonin-induced contractions of rabbit cerebral vascular smooth muscle by calcium antagonistic dihydropyridines. Circ Res 48:650–657

  22. Towart R, Stoepel K (1979) The vascular mechanisms of action of Bay e 5009, a new calcium antagonist with a potent, antihypertensive action. Naunyn-Schmiedeberg's Arch Pharmacol 308 (Suppl): R18

  23. Van Meel JCA, De Jonge A, Wilffert B, Kalkman HO, Timmermans PBMWM, Van Zwieten PA (1981a) Vascular smooth muscle contraction initiated by postsynaptic α2-adrenoceptor activation is induced by an influx of extracellular calcium. Eur J Pharmacol 69:205–208

  24. Van Meel JCA, De Jonge A, Kalkman HO, Wilffert B, Timmermans PBMWM, Van Zwieten PA (1981b) Organic and inorganic calcium antagonists reduce vasoconstriction in vivo mediated by postsynaptic α2-adrenoceptor. Naunyn-Schmiedeberg's Arch Pharmacol 316:288–293

  25. Van Meel JCA, De Jonge A, Timmermans PBMWM, Van Zwieten PA (1981c) Selectivity of some alpha-adrenoceptor agonists for peripheral alpha1- and alpha2-adrenoceptors in the normotensive rat. J Pharmacol Exp Ther 219:260–267

  26. Van Meel JCA, De Zoeten K, Timmermans PBMWM, Van Zwieten PA (1982) Impairment by nifedipine of vasopressor responses to stimulation of postsynaptic α2-adrenoceptor in ganglion-blocked rabbits. Further evidence for the selective inhibition of postsynaptic α2-adrenoceptor induced pressor responses by calcium antagonists. J Auton Pharmacol 2:13–20

  27. Van Nueten JM, Van Beek J, Janssen PAJ (1978a) Effect of flunarizine on calcium-induced responses of peripheral vascular smooth muscle. Arch Int Pharmacodyn 232:42–52

  28. Van Nueten JM, Van Beek J, Janssen PAJ (1978b) The vascular effects of flunarizine as compared with those of other clinically used vasoactive substances. Arzneimittelforsch 28:2082–2087

  29. Van Rossum JM (1963) Cumulative dose-response curves. Arch Int Pharmacodyn 143:299–330

  30. Van Zwieten PA, Van Meel JCA, De Jonge A, Wilffert B, Timmermans PBMWM (1982) Central and peripheral α-adrenoceptors. J Cardiovasc Pharmacol 4:19–24

  31. Zsóter TT (1980) Calcium antagonists. Am Heart J 99:805–810

Download references

Author information

Correspondence to J. C. A. van Meel.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

van Meel, J.C.A., Towart, R., Kazda, S. et al. Correlation between the inhibitory activities of calcium entry blockers on vascular smooth muscle constriction in vitro after K+-depolarisation and in vivo afterα 2-adrenoceptor stimulation. Naunyn-Schmiedeberg's Arch. Pharmacol. 322, 34–37 (1983).

Download citation

Key words

  • Calcium entry blockers
  • K+-Induced vasoconstriction
  • α2-Adrenoceptors-mediated vasoconstriction
  • Ca2+-Influx inhibition